Can normal people take tucatinib/tucatinib?

Tucatinib/Tucatinib is a drug used to treat specific types of breast cancer. It is not suitable for normal people or people without breast cancer. Tucatinib is a powerful anti-cancer drug designed to precisely target HER2-positive breast cancer cells. For normal people without breast cancer, taking this drug will not only bring no benefits, but may increase unnecessary health risks.

The use of tucatinib needs to be under the guidance of a doctor and is usually used in combination with other drugs to form a complete treatment plan. Normal people taking tucatinib by themselves without the guidance of a doctor may cause adverse reactions or side effects due to improper drug dosage, drug interactions and other reasons. In addition, the side effects of tucatinib cannot be ignored. Although it has achieved remarkable results in the treatment of breast cancer, it may also cause a series of side effects, such as nausea, vomiting, diarrhea, fatigue, abnormal liver function, etc. These side effects may cause unnecessary physical burden and pain to normal people.

In 2023, clinical guidelines were updated with a decision to approve tucatinib in combination with trastuzumab for the treatment of adult patients with RAS wild-type, HER2-positive unresectable or metastatic colorectal cancer who have progressed on fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy. Designated by the FDA as an orphan drug for the treatment of HER2-positive colorectal cancer.

In short, tucatinib is a treatment drug for a specific type of breast cancer. Normal people must not take tucatinib at will. Patients should maintain a rational and scientific attitude, follow the doctor's instructions, and not take any drugs blindly.